Lymphatic mapping for gastric adenocarcinoma

Area of Science:

• Surgical Oncology
• Gastrointestinal Cancer Research
• Diagnostic Pathology

Background:

• The role of lymphadenectomy in gastric carcinoma treatment remains a subject of debate.
• Lymphatic mapping has transformed management in other cancers like melanoma and breast cancer.
• Its application in gastric carcinoma lymphadenectomy is largely unexplored.

Purpose of the Study:

• To investigate the feasibility and utility of lymphatic mapping for guiding lymphadenectomy in gastric carcinoma.
• To assess the accuracy of sentinel lymph node (SLN) identification and metastasis detection.
• To evaluate the potential of SLN biopsy in upstaging gastric carcinoma patients.

Main Methods:

• Lymphatic mapping was attempted in 14 gastric carcinoma cases using perilesional isosulfan blue injection.
• Sentinel lymph nodes (SLNs) were harvested, stained with H&E, and further evaluated with immunohistochemistry.
• Radical gastrectomy with celiac node dissection was performed on all patients.

Main Results:

• SLNs were successfully identified in 14 cases, with an average of 2.8 SLNs per patient.
• Metastatic carcinoma was detected in SLNs of 8 out of 14 patients (57%).
• SLN positivity showed a high positive predictive value (89%) for detecting additional nodal disease, but SLN negativity had a low negative predictive value (50%).

Conclusions:

• Lymphatic mapping is technically feasible for gastric carcinoma, with successful SLN identification in most cases.
• SLN biopsy can lead to upstaging in some patients, potentially influencing adjuvant therapy decisions.
• Further research is warranted to refine this promising technique for gastric cancer management.